New York Times on New Prostate Cancer Tests

New York Times on New Prostate Cancer Tests

There has been a lively debate in the medical community on the best way to screen for prostate cancer. This conversation has spilled in the media, leading some men to believe this is an excuse to avoid discussing prostate cancer with their doctor and/or loved ones.

The New York Times recently published an article entitled “New Prostate Cancer Tests Could Reduce False Alarms.” If you are interested in the detection and treatment of prostate cancer it is well worth reading. The article noted “test developers hope that such savings will make their tests cost-effective, even at prices that will exceed $3,000 in some cases.”

If your doctor suspects a diagnosis of prostate cancer we encourage you to learn more about additional screening procedures that can help you gain clarity on your diagnosis. Every patient’s case is different – it’s essential to talk with your referring urologist or primary care provider. Depending on your case they may recommend a multi parametric MRI of the prostate, which could be followed by a MRI-guided biopsy. These imaging techniques, even out-of-pocket, are less expensive than many of the new tests discussed in the New York Times article.

Please feel free to contact one of our Rolling Oaks Radiology facilities if you would like additional information about prostate cancer screening, or to schedule a MRI-guided prostate biopsy.

Add new comment